2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
US10543189B2 · kind B2 · utility
1Cited by
63References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2019 |
| Grant date | Jan 28, 2020 |
| Priority date | — |
| Expiry date | Aug 16, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.